Skip to content

Author

Vincenzo Laterza

We have 3 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Beyond anticoagulation: Statin therapy and 90-day mortality after breakthrough ischemic stroke in atrial fibrillation

Secondary stroke prevention in patients with atrial fibrillation (AF) who experience an ischemic stroke (IS) despite oral anticoagulation remains challenging, and strategies have focused on antithrombotic optimization or left atrial appendage occlusion. Adjunctive statin therapy might reduce early vascular risk and...

G. Merlino, R. Ornello, L. D'Anna et al. · 0 citations
Review Sep 2026

Glial fibrillary acidic protein in progressive supranuclear palsy: A systematic review and meta-analysis.

Mean blood GFAP concentrations are higher in clinically diagnosed PSP than in healthy controls, although the biological basis and disease specificity of this finding remain uncertain, and GFAP should not be considered a stand-alone diagnostic marker.

G. Magro, Vincenzo Laterza, A. Mechelli et al. · 0 citations
Open access Aug 2026

Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study

Potential causes of breakthrough ischemic stroke are identifiable in about half of breakthrough strokes and are associated with higher risk of recurrence compared with those without, warranting individualized approaches.

Federico De Santis, Matteo Foschi, Francesca Gabriele et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.